Skip to main content

Closed

NVCR: Novocure Ltd Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+18.8% / yr

Operating margin-22.1%

ROIC-26.2%

Financially safe

Stretched

Debt / equity0.69×

Interest coverage-64.4×

Current ratio2.89×

Novocure Ltd

NVCRNASDAQ·USD·Closed

Novocure Ltd

NVCRNASDAQ·USD·Closed

$14.84

−2.56%

$14.84

−$0.39 (2.56%)

52W Range

43thpctl

Volume

0.62×avg

Mkt Cap

1.72BUSD

P/E

-11.4TTM

Div Yield

–ann

52W Range

43thpctl

Volume

0.62×avg

Market Cap

1.72BUSD

P/E Ratio

-11.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings